A survey of 99 mental health service users found that most supported further research into psilocybin (72%) and its medical use (59%), with 55% saying they would accept it if recommended by a doctor; favourable attitudes were more common in younger people, those with prior psychedelic experience, and non‑religious individuals. Nonetheless, significant reservations remained—around one fifth viewed psychedelics as addictive or unsafe and concerns included adverse effects, illegality and relapse risk, while a small minority with psychosis/bipolar still considered it useful despite potential harm.
- Published
- Journal
- Irish Journal of Medical Science
- Authors
- Cleary, S., Corrigan, K., Haran, M., Kelly, J. R., Kelly, Y., Ledden, K., McCandliss, C., McManus, R., O’Keane, V., Rush, G., Trant, R.